Physician profile
Joanne Lenert
NPI 1780694612
$3,244.68
in general payments reported to CMS, 2019-2025
14 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $359 · 2020: $222 · 2021: $907 · 2022: $1,121 · 2023: $334 · 2024: $153 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $636.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $635.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,301.63 | 2019-2022 | |
| Abbvie INC. | $458.08 | 2023-2025 | |
| Sientra, INC. | $299.38 | 2022 | |
| Bard Peripheral Vascular, INC. | $270.28 | 2021 | |
| Integra Lifesciences Corporation | $249.24 | 2020-2023 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Mentor Worldwide LLC | $231.36 | 2019-2024 | Cg Infiltration Tubing, Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Tela Bio, INC. | $126.28 | 2020-2021 | |
| Medtronic, INC. | $101.41 | 2022 | |
| Axogen | $94.26 | 2022-2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Tei Biosciences INC | $38.78 | 2019 | |
| Medline Industries LP | $21.21 | 2019 | |
| Kci USA, INC. | $20.14 | 2021 | |
| Davol INC. | $17.63 | 2021 | |
| Cook Medical LLC | $15.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanne Lenert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.